We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Intellicheck
IDN
$79.6M
| $737K | ﹤0.01% |
+97,637
| New | +$592K |
|
2752
ACNB Corp
ACNB
$655M
| $736K | ﹤0.01% |
28,139
+119
| +0.4% | +$2.95K |
|
2753
RGC Resources
RGCO
$228M
| $736K | ﹤0.01% |
30,442
+3,036
| +11% | +$77.2K |
|
2754
RCI Hospitality Holdings
RICK
$215M
| $730K | ﹤0.01% |
52,643
+12,034
| +30% | +$147K |
|
2755
BayCom
BCML
$333M
| $728K | ﹤0.01% |
56,397
+13,162
| +30% | +$163K |
|
2756
First Capital
FCAP
$214M
| $727K | ﹤0.01% |
10,466
+5,497
| +111% | +$322K |
|
|
CSPR
2757
DELISTED
Casper Sleep Inc.
CSPR
| $722K | ﹤0.01% |
80,463
+69,591
| +640% | +$493K |
|
2758
Global Indemnity Group
GBLI
| $721K | ﹤0.01% |
30,112
-1,927
| -6% | -$46K |
|
|
CUTR
2759
DELISTED
Cutera, Inc.
CUTR
| $716K | ﹤0.01% |
58,865
+1,540
| +3% | +$20.3K |
|
2760
Safe Bulkers
SB
$774M
| $715K | ﹤0.01% |
585,417
-23,493
| -4% | -$25.7K |
|
2761
Turning Point Brands
TPB
$1.74B
| $714K | ﹤0.01% |
28,664
+31
| +0.1% | +$712 |
|
|
BREW
2762
DELISTED
Craft Brew Alliance, Inc.
BREW
| $711K | ﹤0.01% |
46,213
+116
| +0.3% | +$1.77K |
|
2763
First Internet Bancorp
INBK
$255M
| $709K | ﹤0.01% |
42,717
-2,420
| -5% | -$38K |
|
|
OYST
2764
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $709K | ﹤0.01% |
24,572
+11,332
| +86% | +$341K |
|
2765
GrowGeneration
GRWG
$90.7M
| $708K | ﹤0.01% |
+103,453
| New | +$569K |
|
2766
Liquidia Corp
LQDA
$8.02B
| $706K | ﹤0.01% |
83,894
+48,949
| +140% | +$371K |
|
2767
Daktronics
DAKT
$1.04B
| $705K | ﹤0.01% |
161,973
-58,974
| -27% | -$261K |
|
|
ICAD
2768
DELISTED
iCAD Inc
ICAD
| $702K | ﹤0.01% |
+70,234
| New | +$759K |
|
2769
Liquidity Services
LQDT
$1.32B
| $702K | ﹤0.01% |
117,788
+18,600
| +19% | +$98.7K |
|
2770
Universal Technical Institute
UTI
$1.59B
| $702K | ﹤0.01% |
+100,945
| New | +$663K |
|
2771
Pulse Biosciences
PLSE
$3.02B
| $701K | ﹤0.01% |
67,000
+26,605
| +66% | +$240K |
|
2772
Protagonist Therapeutics
PTGX
$9.44B
| $701K | ﹤0.01% |
90,772
-8,301
| -8% | -$104K |
|
2773
Donegal Group Class A
DGICA
$714M
| $700K | ﹤0.01% |
49,281
-2,130
| -4% | -$30.4K |
|
2774
Rush Enterprises Class B
RUSHB
$6.14B
| $699K | ﹤0.01% |
44,107
-2,106
| -5% | -$31.2K |
|
|
GDEN
2775
DELISTED
Golden Entertainment
GDEN
| $698K | ﹤0.01% |
78,262
+1,298
| +2% | +$12.1K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.